Alessandra Guida

Biosafety Measures, Technology Risks and the World Trade Organization

Thriving and Surviving in the Age of Biotech

• Gebundenes Buch

Produktbeschreibung

This book examines the work of the World Trade Organization, with a focus on the capacity of its judiciary to strike a reasoned balance between free trade in biotechnology and biosafety as to promote the 2030 Agenda for Sustainable Development and its Sustainable Development Goals.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Taylor & Francis
• Seitenzahl: 318
• Erscheinungstermin: 23. Dezember 2022
• Englisch
• Abmessung: 234mm x 156mm x 21mm
• Gewicht: 671g
• ISBN-13: 9781032351865
• ISBN-10: 1032351861
• Artikelnr.: 65912482

Autorenporträt

Alessandra Guida is Lecturer in Climate, Justice & Human Rights Law and the Challenges of Technology Corporate Environmental Law Clinical Law in the School of Law at Queen's University Belfast.

Inhaltsangabe

Acknowledgements
List of Treaties and Declarations
List of Cases
List of Figures and Tables
Glossary
PART I Context - international trade in biotechnology
1 International trade in biotechnology and protection of biosafety: an
uneasy combination
PART II Addressing normative, judicial and epistemic challenges in trading
biotechnology under the WTO
2 Normative, judicial and epistemic challenges for the WTO: free trade and
biosafety
3 Proportionality analysis to address WTO normative and judicial challenges
in the context of biotechnology
4 The precautionary principle to address WTO epistemic challenges in the
context of biotechnology
PART III Analysis of WTO biotechnology legal disputes
5 Introduction to and key reasons for a critical analysis of WTO
biotechnology legal disputes
6 Allocation of the burden of proof to establish a prima facie case and
standard of review to examine biotechnology matters: preliminary issues in
the WTO jurisprudence on biotechnology
7 Adopting precautionary measures on biosafety in contexts of sufficient
scientific evidence
8 Adopting precautionary measures on biosafety in contexts of insufficient
scientific evidence
PART IV Final insights
9: Conclusion
Index